Jeuveau™ Treatment Experts in Arlington, VA

Jeuveau, or “Newtox,” is an injectable neurotoxin similar in structure to BOTOX®. As the first new injectable treatment to hit the market in a decade, Jeuveau is manufactured by Evolus and approved by the FDA to smooth away frown lines and create a refreshed, more youthful look.

Juveau™ Before and After

Jeuveau™ vs. Botox: How is Jeuveau Different

Like BOTOX®, Jeuveau is used to temporarily paralyze the underlying facial muscles in the face, creating a smoother look and alleviating frown lines, and results last approximately three months. Jeuveau offers several advantages, and is quickly becoming the most requested alternative to BOTOX® because:

• Smooths lines and wrinkles like BOTOX®, at less cost.
• May be more effective if BOTOX® is no longer achieving results.
• May act more quickly than BOTOX®, and lasts longer for some people

As with BOTOX®, Jeuveau requires upkeep in order for the results to last long-term. The decreased price of this particular injectable treatment may therefore make Jeuveau more accessible to many people who want to retain a more youthful look, or ward off the development of lines and wrinkles.

How does Jeuveau™ work ?

Jeuveau™ prevents your nerves from telling your facial muscles to flex.¹ The result? In clinical trials, Jeuveau™ was shown to temporarily improve the appearance of moderate to severe frown lines.¹ In 2 long-term safety studies, patients received an average of 3 treatments over the course of 1 year.

What is a Jeuveau™ session like?

If it’s your first time getting a treatment, you may be a little nervous. And that’s okay! Localized pain, infection, inflammation, tenderness, swelling, erythema, and/or bleeding/bruising may be associated with the injection.

What are the results can be expected of Jeuveau™?

In our 2 major clinical trials, when we checked at the 30-day mark, 67.5% of patients in 1 study and 70.4% of subjects in a second study were responders defined as a 2-point composite improvement agreed upon by physician and patient.